期刊文献+

二甲双胍辅助化疗治疗对卵巢癌患者术后外周血相关因子水平的影响

Effect of adjuvant metformin chemotherapy on the levels of relevant factors in peripheral blood in patients with ovarian cancer
原文传递
导出
摘要 目的探讨二甲双胍辅助化疗治疗对卵巢癌患者术后外周血D-二聚体、溶血磷脂酸(LPA)和白细胞介素-6 (IL-6)水平的影响。方法选取2017年1月至2018年6月间昆明医科大学附属肿瘤医院收治的100例卵巢癌术后患者,按照不同治疗方法分为顺铂组和联合组,每组50例。顺铂组患者采用顺铂联合紫杉醇(TC方案)化疗治疗,联合组患者采用二甲双胍辅助化疗方案治疗,比较两组患者的临床疗效和外周血D-二聚体、LPA及IL-6水平。结果顺铂组患者治疗有效率和控制率分别为28. 0%和68. 0%,联合组患者分别为46. 0%和80. 0%,联合组均高于顺铂组患者,差异均有统计学意义(均P <0. 05)。治疗后,联合组患者外周血D-二聚体、LPA和IL-6水平均优于顺铂组,差异均有统计学意义(均P <0. 05)。结论二甲双胍辅助顺铂对卵巢癌患者术后的预后作用积极,可提高临床疗效,改善外周血D-二聚体、LPA和IL-6水平,值得临床推行。 Objective To analyze the effects of adjuvant metformin chemotherapy on the levels of D-dimer,lysophosphatidic acid( LPA) and interleukin-6( IL-6) in peripheral blood in patients with ovarian cancer after operation. Methods A total of 100 patients with ovarian cancer treated at Cancer Hospital Affiliated to Kunming Medical University from January 2017 to June 2018 were selected and divided into cisplatin group and combination group according to different treatment methods with 50 patients in each group.Cisplatin group was treated with cisplatin plus paclitaxel( TC regimen),and the combination group was treated with metformin adjuvant to chemotherapy regimen. The clinical efficacy,and the levels of D-dimer,LPA and IL-6 in peripheral blood was compared between the two groups. Results The efficacy rate and control rate was 28. 0% and 68. 0% respectively for the cisplatin group and 46. 0% and 80. 0% respectively for the combination group with the combination group higher than the cisplatin group( all P < 0. 05). After treatment,the levels of D-dimer,LPA and IL-6 in peripheral blood were better in the combination group than in the cisplatin group( all P < 0. 05). Conclusion Adjuvant metformin chemotherapy has a positive effect on the prognosis in patients with ovarian cancer after operation. It can improve the clinical efficacy and the levels of D-dimer,LPA and IL-6 in peripheral blood,and it is worthy of clinical application
作者 刘坤 付凤莲 杨勇 杨梅 陈云兰 鲁凤丽 LIU Kun;FU Feng-lian;YANG Yong;YANG Mei;CHEN Yun-lan;LU Feng-li(Department of Cadre Ward ,Cancer Hospital Affiliated to Kunming Medical University,Kunming 650118,China;Department of Urology,Cancer Hospital Affiliated to Kunming Medical University,Kunming 650118,China)
出处 《中国肿瘤临床与康复》 2019年第1期70-72,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
基金 云南省卫计委资助项目(2014NS026)
关键词 二甲双胍 顺铂 卵巢肿瘤 外周血D-二聚体 溶血磷脂酸 白细胞介素-6 Metformin Cisplatin Ovarian neoplasms D-dimer in peripheral blood Lysophosphatidic acid Interleukin-6
  • 相关文献

参考文献10

二级参考文献68

  • 1刘南海,朱祖余,刘春棋,曾繁银,黄晓峰.缺血性脑卒中患者血浆溶血磷脂酸水平变化及其临床意义探讨[J].中山大学学报(医学科学版),2004,25(5). 被引量:3
  • 2Kalogera E,Dowdy SC,Bakkum-Gamez JN.Preserving fertility in young patients with endometrial cancer:current perspectives[J].Int J Womens Health,2014,6:691-701.
  • 3Schmandt RE,Iglesias DA,Co NN,et al.Understanding obesity and endometrial cancer risk:opportunities for prevention[J].Am J Obstet Gynecol,2011,205(6):518-525.
  • 4Zhang ZH,Su PY,Hao JH,et al.The role of preexisting diabetes mellitus on incidence and mortality of eudometrial cancer:a meta-analysis of prospective cohor studies[J].Int J Gynecol Cancer,2013,23(2):294-303.
  • 5Nevadunsky NS,van Arsdale A,Strickler HD,et al.Metformin use and endometrial cancer survival[J].Gynecol Oncol,2014,132(1):236-240.
  • 6Emami Riedmaier A,Fisel P,Nies AT,et al.Metformin and cancer:from the oldmedicine cabinet to pharmacological pitfalls and prospects[J].Trends Pharmacol Sci,2013,34(2):126-135.
  • 7Kim JJ,Kurita T,Bulun SE.Progesterone action in endometrial cancer,endometriosis,uterine fibroids,and breast cancer[J].Endocr Rev,2013,34(1):130-162.
  • 8Nevadunsky NS,van Arsdale A,Strickler HD,et al.Metformin use and endometrial cancer survival[J].Gynecol Oncol,2014,132(1):236-240.
  • 9Soranna D,Scotti L,Zambon A,et al.Cancer risk associated with use of metformin and sulfonylurea in type 2diabetes:a meta-analysis[J].Oncologist,2012,17(6):813-822.
  • 10Rattan R,Giri S,Hartmann LC,et al.Metformin attenuates ovarian cancer cell growth in all AMP-kinase dispensable manner[J].J Cell Mol Med,2011,15(1):166-178.

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部